By Leslie Cohen, Psychedelic Guide
When someone is living with a life-limiting or terminal diagnosis, the fear is not only about pain or physical decline. What often weighs heaviest is emotional and existential: Why is this happening to me? What happens next? How do I enjoy life while I am suffering, while I am dying? For some, death feels imminent and terrifying. For many, anxiety crowds out the ability to be present, making it hard to talk openly with loved ones or to enjoy the time that remains.
Traditional therapies can help, but they do not always reach the depth of this kind of fear in ways that provide real relief. In recent years, psychedelic-assisted therapies, including ketamine, have emerged as a potential option for easing end-of-life anxiety when used carefully, thoughtfully, and within a broader context of compassionate care.
What the Research Shows
In a 2024 review that examined nine clinical studies involving more than 600 people with terminal or life-limiting illnesses, researchers found that psychedelic-assisted treatments were associated with substantial reductions in both depression and anxiety compared to standard care or placebo. The improvements were not small or subtle, but large enough to be considered clinically clinically meaningful, suggesting that many participants experienced real relief rather than just marginal change.
Participants also showed less hopelessness and emotional distress, along with greater acceptance of death and a stronger sense of meaning in life. Some studies also noted improvements in spiritual or existential well-being, helping people feel more at peace with uncertainty and with the possibilities of what comes after death.
How Ketamine Works in This Context
Existential anxiety can feel relentless. Thoughts and fears can run rampant, thoughts about not having enough time left, fears about what is coming and about leaving loved ones. Ketamine appears to quiet the brain systems involved in this kind of repetitive thought patterning, creating a sense of psychological space. Many clients describe the fear as still present, but no longer overwhelming. It is there, but it no longer fills the whole expanse of emotional space.
The speed with which ketamine works is also an important benefit. While many conventional antidepressants take weeks to have an impact, time that is especially precious to people with terminal diagnoses, ketamine can reduce severe anxiety and despair within hours or days. That relief can be transformative. It may allow someone to sleep through the night for the first time in weeks, to speak honestly with a loved one, or simply to sit quietly without being overtaken by panic.
For many, this shift feels like a gift: enough space to connect, reflect, and feel love.
Importantly, ketamine is not a standalone solution. Its benefits are strongest when integrated into a broader circle of support that may include palliative care, psychotherapy, spiritual counseling, end-of-life doula care, and open conversations about death. Preparation and integration matter. With the right support, the shifts that occur during psychedelic treatment can translate into greater emotional presence, reduced dread, and a stronger ability to make choices that align with what is most valued.
